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We addressed the relationship between the origin and evolution of human immunodeficiency virus type 1
(HIV-1) variants and disease outcome in perinatally infected infants by studying the V3 regions of viral
variants in samples obtained from five transmitting mothers at delivery and obtained sequentially over the first
year of life from their infected infants, two of whom (rapid progressors) rapidly progressed to having AIDS.
Phylogenetic analyses disclosed that the V3 sequences from each mother-infant pair clustered together and
were clearly distinct from those of the other pairs. Within each pair, the child’s sequences formed a mono-
phyletic group, indicating that a single variant initiated the infection in both rapid and slow progressors.
Plasma HIV-1 RNA levels increased in all five infants during their first months of life and then declined within
the first semester of life only in the three slow progressors. V3 variability increased over time in all infants, but
no differences in the pattern of V3 evolution in terms of potential viral phenotype were observed. The numbers
of synonymous and nonsynonymous substitutions varied during the first semester of life regardless of viral
load, CD41-cell count, and disease progression. Conversely, during the second semester of life the rate of
nonsynonymous substitutions was higher than that of synonymous substitutions in the slow progressors but
not in the rapid progressors, thus suggesting a stronger host selective pressure in the former. In view of the
proposal that V3 genetic evolution is driven mainly by host immune constraints, these findings suggest that
while the immune response to V3 might contribute to regulating viral levels after the first semester of life, it
is unlikely to play a determinant role in the initial viral decline soon after birth.
Mother-to-child transmission of human immunodeficiency
virus type 1 (HIV-1) accounts for more than 95% of the cases
of pediatric AIDS. Moreover, about one-third of these infected
infants will develop severe symptoms of disease and/or severe
immunodepression by 1 year of age. The timing of transmis-
sion, the pathogenic potential of the transmitted variants, and
the host’s capability to control the growth of the viral popula-
tion have each been postulated to explain the observed differ-
ences in progression to disease (for a review, see reference 48).
Although the precise timing of vertical transmission cannot be
pinpointed, it has been proposed that detection or lack of
detection of the virus in the child at birth might reflect viral
transmission in utero or during the intrapartum period (18). By
using highly sensitive PCR-based methods to directly detect
HIV-1, we and others (3, 15, 19, 30) demonstrated that a
consistent proportion of infants who are subsequently recog-
nized as infected do not have detectable virus levels in their
peripheral blood cells at birth. Further studies on the dynamics
of HIV-1 replication after birth (16) and the appearance of the
child’s autochthonous antibodies (14, 49) indicate that HIV-1
transmission occurs mainly late in pregnancy or at delivery.
Most of the investigations that have evaluated the genetic
diversity of the virus found a highly homogeneous viral popu-
lation in newborns, thus indicating that a limited number of
variants or even one variant initiated the infection in the in-
fants (1, 38, 54, 58, 67). However, few studies have addressed
the relationship between acquired HIV-1 variants and their
evolution over time in relation to disease outcome (26, 58).
An accumulating body of evidence indicates that disease
progression in adults (37, 47) as well as in infants (16, 18) is
directly related to the level of virus replication; multiple viral
factors, such as tropism and replicative capacity, and host fac-
tors, including cellular and humoral immune responses, are
likely to determine virus levels.
Genetic analysis of the third variable region (V3) of the env
gene has provided information about the potential phenotype
of the virus and host-dependent constraints, since this region
contains determinants involved in a number of biological prop-
erties of the virus, including tropism and cytopathicity (5, 8, 11,
27, 55), as well as recognition sites for both humoral and
cellular T-cell immune responses (45, 50–52, 59, 60). Indeed,
specific amino acid changes in V3 have been associated with
the appearance of syncytium-inducing (SI) viral variants (10,
24) and resistance to neutralizing antibodies (63), and it has
been proposed that a rapid evolution of antigenic sites such as
the V3 region might exceed the capacity of the immune system
to control virus growth (41, 42). According to this theory, the
V3 region would evolve more rapidly in individuals progressing
to AIDS than in those who remain asymptomatic longer (41,
42). A study of twins with different disease courses reported a
higher increase in sequence diversity, paralleled by a lower
immune response, in the infant who progressed rapidly to
AIDS (rapid progressor) than in the slow-progressor infant
(26). Higher rates of sequence divergence and nonsynonymous
nucleotide substitutions within the V3 region have also been
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reported for two children who progressed faster to AIDS com-
pared to four slower-progressing infants (58). However, it has
recently been demonstrated that an increase in genetic diver-
sity was correlated with a slower CD41-cell decline and a
prolonged asymptomatic period in adults who had been mon-
itored since primary infection (64). Furthermore, the observa-
tion that the rate of nonsynonymous nucleotide substitutions
was higher in slow progressors than in subjects who progressed
rapidly to AIDS and was correlated with the duration of the
immunocompetent period (33, 64) leads to the proposal that
the evolution of the viral population is driven mainly by host
immune system selective forces.
To better clarify the transmitted variants and their evolution
in relationship to disease outcome, we studied the V3 regions
of the viral variants present in samples collected at delivery
from five mothers and collected sequentially over the first year
of life from their infected infants. The evolution of the V3
region was compared to the CD41-cell number, plasma HIV-1
RNA levels, biological phenotype of the virus, and timing of
seroconversion.
MATERIALS AND METHODS
Patients. Five HIV-1-infected mother-infant pairs were examined in this study.
The women attended the Gynecology and Obstetrics Department of the Uni-
versity of Padova. Maternal samples were collected within 7 days of delivery. The
clinical stage according to the Centers for Disease Control (CDC) (6) and the
CD41-cell count were provided with the samples. Peripheral blood samples from
the children were supplied by the Pediatrics Department of the University of
Padova. All of the children were full-term infants born by spontaneous vaginal
delivery; none were breast fed. The infection status of the children was defined
by virus isolation and PCR as previously described (13, 15). The children were
followed clinically and immunologically every month during the first 3 months of
life and then every 2 to 3 months; clinical and immunological statuses were
defined according to the CDC criteria (7).
Sample preparation. Heparinized peripheral blood samples were centrifuged
over Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) density gradients; plasma
was recovered from the upper phase, centrifuged at 1,000 3 g for 15 min to
ensure cell-free specimens, and stored at 280°C until further analysis. Peripheral
blood mononuclear cells (PBMCs) were recovered from the top of the Ficoll
gradient, washed twice with phosphate-buffered saline, and counted. Two million
PBMCs were lysed for 1 h at 56°C in 500 ml of TE buffer (10 mM Tris-HCl [pH
8] and 0.1 mM EDTA) containing 0.001% Triton X-100, 0.0001% sodium do-
decyl sulfate, and 600 mg of proteinase K/ml. After lysis, proteinase K was
inactivated by heating the mixture for 15 min at 94°C. Detection of HIV-1 by
PCR was performed directly on aliquots of the lysed cells as previously reported
(15). The remaining cells were resuspended in RPMI medium supplemented
with 10% fetal calf serum and 10% dimethyl sulfoxide and then were cryopre-
served for biological assays.
Nested PCR and cloning. Nested PCR amplifications of proviral DNA were
carried out on lysed PBMCs. Only one sample was processed at a time to avoid
cross-contamination. The V3 region was amplified with the outer primer pair
V3A (59 TACAATGTACACATGGAATT 39) and V3D (59 ATTACAGTAGA
AAAATTCCCC 39) and the inner primers V3B (59 TGGCAGTCTAGCAGA
AGAAG 39) and V3C (59 CTGGGTCCCCTCCTGAGG 39). The primer-bind-
ing sites were highly conserved between sequences of geographical variants of
HIV-1 (39); their positions in HIV-1IIIB (clone HXB2) are as follows (59 to 39):
V3A, nucleotides (nt) 6957 to 6976; V3B, nt 7009 to 7028; V3C, nt 7314 to 7331;
and V3D, nt 7361 to 7381 (57). The first-round PCRs were performed with 25 ml
of lysed PBMCs, corresponding to 105 cells, in a 100-ml reaction mixture con-
taining 20 nmol of each deoxynucleoside triphosphate, 50 pmol of each of the
outer primers, and 2 U of Taq DNA polymerase (Perkin-Elmer Cetus, Norwalk,
Conn.). Forty cycles were carried out in a Gene Amp PCR System 9600 thermal
cycler (Perkin-Elmer), each consisting of 30 s at 94°C, 30 s at 49°C, and 30 s at
72°C, followed by one cycle at 72°C for 5 min. Five microliters of the first-round
PCR was amplified in a nested PCR with 80 pmol of the inner primers; 40 cycles
were run, each consisting of 30 s at 94°C, 30 s at 57°C, and 30 s at 72°C, followed
by a final extension at 72°C for 5 min. Appropriate negative controls (105
HIV-1-negative A301 cells, lysis buffer, and distilled water) were included in each
set of reactions. All negative controls from the first round of amplification were
included in the second amplification step. The sensitivity of nested PCR was
assessed by using 8E51 cells, which contain a single proviral DNA copy of HIV-1
per cell, serially diluted in 105 PBMCs separated from heparinized blood of a
healthy donor; 5 of 10 samples that were calculated to contain one 8E51 cell
yielded the expected product following nested PCR. This result is in agreement
with the reported sensitivity of nested PCR to amplify a single HIV-1 copy (36).
Two separate PCRs for each sample were performed for subsequent cloning.
The amplified products were separated on a 2.5% preparative low-melting-point
agarose gel (NuSieve; FMC, Rockland, Maine). The band of the appropriate size
(322 bp) was excised and purified by using the Wizard PCR Preps DNA Purifi-
cation System (Promega, Madison, Wis.) according to the manufacturer’s in-
structions and then cloned by using the TA cloning kit (Invitrogen, San Diego,
Calif.). Four nanograms of the amplified products was ligated to 50 ng of pCRII
vector with 4 U of T4 ligase for 16 h at 14°C and transformed into competent
cells of Escherichia coli INVaF9. Clones were color selected on indicator plates
containing 50 mg of ampicillin per ml and 40 mg of 5-bromo-4-chloro-3-indolyl-
b-D-galactopyranoside (X-Gal) per ml. White colonies were selected and ampli-
fied in culture, and bacterial DNA was recovered by using a DNA purification kit
(BIO101, RPM Inc., Vista, Calif.), according to the manufacturer’s instructions.
The presence of the insert in the plasmid clones was screened by digestion with
10 U of EcoRI restriction enzyme (Boehringer, Mannheim, Germany); the insert
was screened for appropriate size and relative quantity by electrophoresis on an
0.8% agarose gel.
Sequencing. Nucleotide sequencing of the cloned PCR products (9 to 24
clones for each sample) was performed by the Sanger dideoxynucleotide method,
using the Sequenase version 2.0 kit (United States Biochemical Corp., Cleveland,
Ohio). Each clone was sequenced in the forward and reverse directions with the
V3B and V3C primers. One microgram of the double-stranded plasmid DNA
was mixed with 12 pmol of primer and heat denatured for 5 min; the annealing
step was carried out for 1 min at room temperature. The labeling reaction was
performed on ice for 3 min in a final volume of 20 ml containing 20 mM Tris-HCl
(pH 7.5), 10 mM MgCl2, 25 mM NaCl, 5 mM dithiothreitol, 75 nM each
deoxynucleoside triphosphate, 5 mCi of [a-33P]dATP (Amersham, Buckingham-
shire, United Kingdom), and 3 U of Sequenase. Four-microliter aliquots of the
mixtures were combined with 2.5 ml of each termination mixture (ddATP,
ddCTP, ddTTP, and ddGTP). After 5 min at 37°C, 4 ml of stop solution (95%
formamide, 20 mM EDTA, 0.05% bromophenol blue, and 0.05% xylene cyanol)
was added. The sequencing products were denatured at 80°C for 3 min, and 10-ml
aliquots were resolved by electrophoresis on 8% polyacrylamide denaturing gels
in a sequencing apparatus (GIBCO-Bethesda Research Laboratories, Gaithers-
burg, Md.); the gels were then exposed for 16 h to X-OMAT AR film (Eastman
Kodak, Rochester, N.Y.).
To calculate the rate of misincorporations introduced during PCR, cloning,
and sequencing, 10 clones from two different PCR amplifications of 8E51 cells
were sequenced as described above; only one point mutation was observed,
corresponding to a misincorporation rate of 1/1,890 (0.05%).
Sequence analysis. The sequence analysis program Microgenie (IntelliGenet-
ics, Inc., Mountain View, Calif.) was used to record and translate V3 sequences.
Nucleotide and translated amino acid sequences from each mother-child pair
were aligned by using the Clustal V program (25). The alignments were then
adjusted by hand, and nucleotide gaps were introduced to maintain translation
integrity. Consensus amino acid sequences were derived by assigning the de-
duced amino acid found in more than 50% of the clones to each position.
Phylogenetic analysis was conducted with programs from version 3.52c of the
Phylogeny Inference Package (PHYLIP) (21). Nucleotide sequence distances for
all pairwise sequence comparisons were estimated by means of the generalized
two-parameter (maximum-likelihood) model, which uses the transition proba-
bility formulas of Kishino and Hasegawa (29) (program DNADIST). In-
trasample and intersample sequence variations were expressed as the mean
distance for all pairwise comparisons between sequences obtained within a sam-
ple and from different samples, respectively. Phylogenies were reconstructed for
each mother-child pair by both the neighbor-joining method (53) (program
NEIGHBOR) and the Fitch-Margoliash distance method (23) (program
FITCH); both tree construction methods were employed in order to increase
confidence in the reconstructed phylogenies. Bootstrap resampling (20) was
applied to the neighbor-joining trees (programs SEQBOOT and CONSENSE)
to assign approximate confidence limits to individual branches.
The genetic variability for each sample was calculated from the amino acid
sequences by using the Simpson index, calculated as D 5 Sini2/n2, where ni
denotes the number of type i sequences in the sample and n denotes the total
number of sequences (41). The number of synonymous substitutions per poten-
tial synonymous site (Ds) and the number of nonsynonymous substitutions per
potential nonsynonymous site (Dn) for each set of sequences from the different
time points were calculated by using the method of Nei and Gojobory (40),
incorporating the Jukes-Cantor correction for multiple substitutions, as imple-
mented in the MEGA program (32).
Viral DNA and RNA quantitation. HIV-1 proviral DNA in cells and genomic
HIV-1 RNA in plasma samples were quantified by using competitive DNA-PCR
and competitive reverse transcription-PCR, respectively, as previously reported
(16). Briefly, to quantify proviral DNA, replicate portions of lysed cells (15 ml of
cell sample, corresponding to 60,000 cells) were amplified along with 2 ml of
increasing copy numbers of competitor plasmid pSPLI-II (16). To quantify RNA,
virion-associated RNA was obtained from plasma by an affinity capture method;
replicate portions of RNA samples (2 ml, corresponding to 30 ml of plasma) were
reverse transcribed along with 2 ml of increasing copy numbers of competitor
RNA transcribed from pSPLI-II. Amplification was carried out in a 100-ml final
volume with 100 pg of the primer pair 1-2II, specific for highly conserved regions
of HIV-1 and corresponding to the following HIV-1 MN sequences (59-39): nt
696 to 723, upstream of the first 59 splice site (primer 1), and nt 914 to 889 within
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gag (primer 2II). To increase the sensitivity of the assay, the sense primer was
radiolabeled with [g-32P]dATP. Forty-five amplification cycles were run, each
consisting of 50 s at 94°C, 45 s at 62°C, and 50 s at 72°C. A 30-ml aliquot of each
100-ml PCR mixture was run on a polyacrylamide gel and exposed to an X-ray
film for 2 to 4 h at 280°C. The sizes of the competitor and wild-type amplified
products were 240 and 218 bp, respectively. The peak areas of the amplified
bands were measured by densitometric scanning (ULTRASCAN XL; LKB,
Pharmacia). The logarithm of the ratio between the optical density values of
competitor and wild-type amplified products (y axis) was plotted against the
logarithm of the competitor copy number (x axis), and a linear regression curve
was extrapolated.
Viral phenotype analysis. Viral isolation was performed as previously reported
by culturing patient PBMCs with phytohemagglutinin-stimulated donor PBMCs
(13). Isolates were defined as rapid/high, slow/high, or slow/low according to the
day of p24 antigen appearance and the levels of p24 in the supernatants of the
primary coculture (13). HIV-1 isolates obtained from the primary cocultures
were propagated by a single short-term passage (7 days) in PBMCs; supernatants
were collected, centrifuged at 15,000 3 g for 1 h, and then filtered through
0.22-mm-pore-size filters (Millipore, Bedford, Mass.). The virus content was
quantified by measuring HIV-1 p24 protein. Individual isolates were aliquoted,
stored at 280°C, and then used to evaluate infectivity in primary monocyte-
derived macrophages and peripheral blood lymphocytes and in the T-cell line
MT-2, as previously described (43).
Autochthonous-antibody production. De novo synthesis of antibodies to
HIV-1 in infants was estimated by Western blot profiles and/or an enzyme-linked
immunosorbent assay with HIV-1-derived synthetic peptides as antigens, exactly
as previously reported (14, 17).
Nucleotide sequence accession numbers. The sequences reported here have
been deposited in the GenBank database under accession no. U74767 to 74976
and U74987 to U75185.
RESULTS
Clinical status of patients. The characteristics of the five
mother-child pairs studied are summarized in Table 1. Mater-
nal blood samples were collected at delivery in three cases
(M2, M3, and M4) and at 7 days after delivery in two others
(M1 and M5). All of the mothers were of Italian origin and
formerly were intravenous-drug users. All mothers but one
were asymptomatic during their pregnancy, and none under-
went antiretroviral therapy during pregnancy.
Four of the infants born to these mothers were tested for
HIV-1 infection by PCR and virus culture at birth; infant C5
was tested on day 7 and was found to be HIV-1 positive at this
first examination. The other infants were found to be HIV-1
negative at birth but were HIV-1 positive at their second ex-
amination, which was performed within 1 month of birth (13,
16). According to the CDC criteria (7), the children were
classified as asymptomatic (category N), mildly symptomatic
(category A), moderately symptomatic (category B), or se-
verely symptomatic (category C); the immunological status was
defined as class 1 (no immunodepression), 2 (moderate immu-
nodepression), or 3 (severe immunodepression) on the basis of
the number of CD41 cells per microliter as adjusted for age
(7). Infants C4 and C5, who developed the symptoms listed in
category C and/or severe immunodepression within the first
year of life, were classified as rapid progressors, according to
the definition of the Consensus Workshop on Pediatric AIDS
(61). Infant C4 developed Pneumocystis carinii pneumonia by 3
months of age, while infant C5 showed severe immunodepres-
sion (,750 CD41 cells/ml) by 5 months of age and developed
encephalopathy by 10 months of age; infants C4 and C5 started
therapy with zidovudine at 4 and 6 months, respectively. The
remaining three infants (C1, C2, and C3) were classified as
slow progressors; within the first year of life, they showed
lymphadenopathy (C1 and C3) or hepatosplenomegaly (C2),
and over the course of 4.5 years (mean follow-up time), none
has developed severe immunodepression or progressed to cat-
egory C. Sequential samples collected over the first year of life
at the time points listed in Table 1 were employed for genetic
analysis.
Nucleotide sequence variability. To examine the origin and
evolution of HIV-1 genotypes in infected infants, proviral se-
quences from the maternal PBMC sample at delivery and the
infants’ sequential samples were amplified by nested PCR and
cloned into the vector pCRII; a panel of 9 to 24 clones, each
containing sequences spanning the V3 domain and flanked 59
and 39 by 60 and 21 bp, respectively, was sequenced from each
of the studied samples.
The infants’ samples showed a more homogeneous viral
population (0 to 1.53% intrasample mean nucleotide dis-
tances) than the maternal samples (1.34 to 4.12% intrasample
mean nucleotide distances) (Fig. 1A). The initial genetic vari-
ations of sequences from infants C1, C2, C3, C4, and C5 were
0.22, 0.37, 1.20, 0.71, and 0%, respectively. Heterogeneity in-
creased with age in all of the infants with the exception of C3;
however, after an initial decrease (from 1.20 to 0.81%), an
increase in sequence variability (from 0.81 to 1.53%) was de-
tected in this child as well. The increase in HIV-1 variability
over time was confirmed by an intersample analysis between
sequences from the first sample and each subsequent sample,
which showed an increase in the mean nucleotide distance
values (Fig. 1A).
The mean nucleotide distances between sequences from the
TABLE 1. Times of sampling and clinical data for
mother-child pairs
Pair Sample Code Clinicalstagea
HIV-1
detection
at birth
Time of testing for
genetic analyses
(days after
delivery)
HIV-1 DNA
copies/105
PBMCs
1 M1 2222 IV 7 382
C1.1 2243 N1 2 37 296
C1.2 2415 A1 184 469
C1.3 2564 A1 296 343
2 M2 891 II 1 73
C2.1 982 N1 2 77 327
C2.2 1143 A1 186 98
C2.3 1525 A1 400 265
3 M3 892 II 1 92
C3.1 996 A1 2 85 314
C3.2 1145 A1 190 112
C3.3 1461 A1 384 335
4 M4 1101 II 1 237
C4.1 1102 B1 2 29 591
C4.2 1223 C1 90 480
C4.3 1588 C2 315 2,237
5 M5 2693 II 7 193
C5.1 2663 A1 1 7 26
C5.2 2726 B1 48 1,386
C5.3 2848 B3 137 1,096
C5.4 3223 C3 390 1,016
a The mother’s clinical stage was defined according to the CDC criteria for
adults (6). The child’s clinical stage was defined according to the CDC criteria for
children less than 13 years of age (7).
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mother and those in the child’s first sample were 1.76, 4.10,
3.83, 4.20, and 0.95% for pairs 1, 2, 3, 4, and 5, respectively
(Fig. 1A), while the lowest nucleotide distances between se-
quences from mother’s and child’s first sample were 0.54, 2.79,
2.21, 0, and 0% for pairs 1, 2, 3, 4, and 5, respectively (not
shown); interestingly, these values correlated with the child’s
age at time of first sampling (Table 1). The divergence between
the sequences of the child and the mother increased over time,
with the exception of child C3, who showed the highest mean
nucleotide variability (1.77%) over time (Fig. 1A).
Analysis of all sequences within and between pairs disclosed
that mean nucleotide divergence values within each mother-
child pair fell within the range of intrasample variability (from
0.65 to 2.58%); this was significantly lower (P 5 0.0026 [Mann-
Whitney test]) than the interpair variability (8.85 to 14.05%)
(Fig. 1B).
Phylogenetic analyses. A phylogenetic analysis of the se-
quences of the five mother-child pairs with reference se-
quences from the five env clades of HIV-1 disclosed that all of
the sequences belonged to clade B (data not shown), in agree-
ment with the Italian origin of the patients. A phylogenetic tree
was reconstructed by using the neighbor-joining method for all
409 sequences obtained for the mothers and infants in this
study (Fig. 2). The results showed that the sequences from
each mother-infant pair clustered together; the five pairs were
clearly discriminated and well confined within subtrees. High
bootstrap values were observed for the five mother-infant se-
quence sets, as would be expected for epidemiologically unre-
lated individuals, and excluded the possibility of contamination
of the PCRs. Within the phylogenetic tree, the infants’ se-
quences extended further from the putative ancestral node
than those of the corresponding mothers, thus indicating a
FIG. 1. Nucleotide sequence variation in the V3 region of the env gene in five mother-infant pairs, showing intrasample and intersample mean nucleotide distances
within mother-infant pairs (A) and between mother-infants pairs (B). Shown on the diagonal are the mean nucleotide distances from all pairwise intrasample (A) and
intrapair (B) comparisons. Shown below the diagonal are the mean distances between intersample (A) and interpair (B) comparisons. n, number of sequences analyzed
for each sample (A) and pair (B).
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more divergent evolution. Within the subtrees, moreover, the
maternal sequences were distributed into different branches,
thus suggesting a pattern of multiple distinct lineages; con-
versely, in each infant’s sequence set, most of the sequences
from the first time point were clustered in a single branch, thus
suggesting a monophyletic origin of the infection.
To further investigate the relationship between the maternal
and infant sequences, phylogenetic analysis was performed
separately for each mother-child nucleotide sequence set (Fig.
3). In all pairs, the infants’ sequences from the first sample
were more homogeneous than those of the corresponding
mother and clustered tightly within a single branch in the
phylogenetic tree, forming a monophyletic group. In pairs 2
and 3, viral variants of the child clustered distinctly from se-
quences of the mother; this distinction was supported by rela-
tively high bootstrap values (79% for pair 2 and 73% for pair
3). In pairs 4 and 5, some maternal and infant sequences were
intermingled: in pair 4, two minor maternal viral variants that
were separated from the main group clustered with the child’s
sequence group, and in pair 5, the predominant maternal se-
quence was identical to the major sequence detected in the
child at birth. In pair 1, maternal and infant sequences were
distinct at the nucleotide level, but the maternal sequence
displayed by two of nine clones, and located in the phyloge-
netic tree nearest to the child’s sequences, was identical at the
amino acid level to the predominant viral variant detected in
the first sample from the child (Fig. 4). In infants C3 and C4,
the sequences that showed the most divergence from those of
FIG. 2. Unrooted neighbor-joining tree of 409 V3 nucleotide sequences obtained from the five mother-child pairs. Branch lengths are drawn to scale. The scale bar
corresponds to 1% nucleotide sequence divergence. Bootstrap values are expressed as percentages for each branch and represent the percent occurrence of that branch
per 100 bootstrap replicates. Open symbols denote maternal sequences; closed symbols indicate children’s sequences. F, first sample; , second sample; n, third sample;
}, fourth sample. Numbers refer to the number of identical sequences identified in a given sample. p, position in the tree of the set of sequences included in the bracket.
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FIG. 3. Neighbor-joining trees for each of the five mother-infant pairs. Branch lengths are drawn to scale. The scale bars correspond to 1% nucleotide sequence
divergence. The number at the node indicates the proportion of support in 2,000 bootstrap replicates. Open symbols indicate the mother’s sequences; closed symbols
indicate the child’s sequences. F, first sample, , second sample, n, third sample, }, fourth sample. Numbers refer to the number of identical sequences identified in
a given sample. p, position in the tree of the set of sequences included in the bracket.
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FIG. 4. Multiple alignment of deduced amino acid sequences of the V3 regions of 409 sequences derived from the five mother-infant pairs. Position 1 corresponds
to amino acid 276 of the HXB2 envelope protein. Sequences are aligned against the consensus (CONS) sequences derived for each mother-infant pair. The number
of clones obtained from each pair is shown at the end of the consensus sequence. The frequency of clones with identical amino acid sequences for each sample is given
at the end of the sequence. Dots indicate identity with the reference sequence, dashes represent gaps introduced to maximize alignment, and asterisks represent stop codons.
Potential N-linked glycosylation sites are indicated by three dashes above the alignment. The loss of a potential N-linked glycosylation site is indicated by underlined letters.
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the corresponding mothers were detected at the first time point
(Fig. 2 and 3); in both cases, these sequences corresponded to
variants with substitutions seen only once in the sequence set
(clones C3.1.44 and C3.1.47 in child C3 and clone C4.1.12 in
child C4 [Fig. 4]). These sequence changes could represent
either in vitro-introduced misincorporations or randomly oc-
curring substitutions acquired during the first cycles of viral
replication soon after birth.
The evolutionary pattern of the viral variants in C1, C2, C3,
and C4 resembled a “star” phylogeny with branches radiating
from the point at which the majority of the sequences detected
at the first time point were clustered. In infant C3, some of the
sequences derived from the latest sample were located within
the phylogenetic tree nearest to the maternal sequence (Fig.
3). From this analysis, we could not discriminate between a
phenomenon of convergent evolution or the emergence of
additional transmitted maternal variants later in the child’s life.
Amino acid sequence analysis. The deduced amino acid
sequences of the V3 loop and flanking regions obtained for the
five mother-child pairs are presented in Fig. 4. The coding
potential of the envelope open reading frame was maintained
in most of the sequences, with 15 inactivating mutant stop
FIG. 4—Continued.
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codons (nonsynonymous substitutions TGG3TAG or TGA at
position 62) detected in 75,573 bases sequenced; this substitu-
tion was observed at the same position in a previous study (1).
No frameshifts were observed among the 409 sequences, and
the two cysteines involved in disulfide bridge formation of the
V3 loop (at positions 21 and 55 [Fig. 4]) were conserved in all
but one sequence (i.e., cysteine to arginine in clone C1.1.1).
While the maternal virus population displayed a swarm of
genetically distinct variants, in the first sample from each infant
there was a predominant viral variant, representing from 42%
(C3) to 100% (C5) of the viral population. A few minor viral
variants were also detected; the differences between major and
minor intrasample variants were due to randomly occurring
substitutions, which were observed primarily in only one or a
few sequences within each set of clones. A comparison of the
child’s amino acid sequences with those of the corresponding
mother revealed that in all of the infants the predominant
variant was the one most closely related to the maternal se-
quence(s). In particular, in pairs 1 and 4, the child’s predom-
inant variant was identical to a minor maternal variant, while in
pair 5, the child’s predominant variant was identical to a major
maternal variant. For mothers M4 and M5, these variants
corresponded to those intermingled with the infants’ se-
quences in the phylogenetic tree; for mother M1, this variant
corresponded to the one (M1.5) showing the smallest nucleo-
tide distance (0.54%) from the child’s predominant sequence
(C1.1.10). In infants C2 and C3, none of the sequences were
found to be identical to those of the corresponding mother at
either the nucleotide or the amino acid level; nevertheless,
within each clone set, the major variant showed the smallest
nucleotide and amino acid divergence from the maternal se-
quences. It is noteworthy that a length polymorphism was
observed in pair 2, with all of the child’s sequences showing an
amino acid insertion at position 45. Interestingly, specific
amino acid residues, i.e., serine at position 38 and phenylala-
nine at position 40, were detected in most of the child’s se-
quences, but only in a minor maternal genotype (M2.25). In
pair 3, a specific amino acid deletion at position 42 was ob-
served in both the mother’s and child’s sequences; although no
specific maternal variant more closely related to the child’s
sequences could be identified, the predominant variant in the
child displayed the highest degree of homology with the ma-
ternal sequences. Therefore, it is likely that the predominant
variant in the first sample constituted the form that initiated
the infection in the child and that minor variants were gener-
ated from the major one by point mutations.
Analysis of sequences derived from subsequent samples dis-
closed that the predominant variant persisted over time in each
infant, even though it became less represented; indeed, its
percentage within the total viral population from the first to
the latest sample changed from 80 to 28%, 88 to 37%, 42 to
9%, 62 to 14%, and 100 to 52% in infants C1, C2, C3, C4, and
C5, respectively. In addition to the expansion of minor vari-
ants, new variants were also detected in the subsequent sam-
ples. Based on a comparison of the phylogenetic and amino
acid analyses, with the exception of those of child C3, none of
these variants appeared more closely related to the maternal
variant than the predominant variant detected in the first sam-
ple. Both conservation and divergence were observed in the
central motif of the V3 loop within the mother-infant sequence
sets. In pair 1, all sequences of both mother and child retained
the GPGR motif; the GPGS motif was highly conserved in
child C2, while all of the sequences of mother M2 except one
(M2.25) showed the GPGR motif. Both the GPGK and GPGR
motifs were detected in the maternal and child sequences of
pair 4, while most of the sequences from pair 5 displayed the
GPFR motif. In the sequence set derived from the samples of
child C3, a shift in the central GPGK motif (detected in 100%
of clones from the first sample) to GPGR (detected in 100% of
maternal clones) was observed in 25 and 54% of clones ob-
tained from the second and third samples, respectively.
The addition of carbohydrate chains to potential glycosyla-
tion sites may modulate the host immune response by obscur-
ing linear epitopes, thus facilitating escape variants (2, 28, 56).
Five potential N-linked glycosylation sites (NXT or NXS se-
quons), located at positions 1, 14, 20, 26, and 56, are present in
the V3 and flanking regions (Fig. 4). Four sites (located at
positions 1, 20, 26, and 56) were fairly conserved among the
clonal sequences of all five mother-child pairs. One site, lo-
cated at position 14, was conserved in all of the sequences of
pairs 1, 2, and 5. In pair 4, this site was absent in all of the
child’s sequences and in 13 of 22 maternal sequences. In pair
3, this site was absent in the majority of the maternal sequences
and in all of the child’s sequences from the first sample; in
subsequent samples, however, this glycosylation site was de-
tected in an increasing number of sequences (2 of 24 and 9 of
22 in the second and third samples, respectively). Given that
the GPGR and GPGK central motifs are common in the
strains of clade B and that the potential N-linked glycosylation
sites are quite variable among primary HIV-1 isolates (39), the
features noted in the subsequent samples of child C3 may
support a phenomenon of convergent evolution rather than a
transmission of multiple maternal genotypes to the infant.
V3 evolution in rapid- and slow-progressor infants. Figure 5
reports the intrasample variability and the numbers of synon-
ymous and nonsynonymous nucleotide substitutions calculated
for the V3 sequences from each child’s sample, along with the
sequential plasma HIV-1 RNA values and CD41-cell counts
(16). As shown in Fig. 5A, all infants exhibited a rapid increase
in plasma viral RNA during the first 4 to 6 weeks of life. After
this period, viral RNA levels decreased by at least 10-fold in
slow-progressor infants C1, C2, and C3 but remained at high
levels (.1,000,000 RNA copies/ml of plasma) in rapid-pro-
gressor infants C4 and C5. Viral decline did not appear to
correlate with the onset of an HIV-1 humoral immune re-
sponse, as autochthonous antibodies could be detected in four
of the five infants, including the two rapid progressors. The
time of seroconversion, estimated as the mean period between
the child’s age at the last negative finding and the first positive
finding for autochthonous-antibody production, ranged from
25 days in child C5 to 94 days in child C2 (14).
Intrasample variability increased progressively over time in
both the rapid- and slow-progressor infants (Fig. 5A). The
pattern of synonymous and nonsynonymous substitutions was
extremely varied in the first months of life, regardless of HIV-1
RNA levels, CD41-cell count, and disease progression (Fig.
5B). Indeed, from the first to the second sample, the number of
intrasample synonymous substitutions decreased in children
C2, C3, and C4 and increased in children C1 and C5; the
number of nonsynonymous substitutions decreased in children
C1 and C3 and increased in children C2, C4, and C5. The mean
Ds/Dn values from the first to the second sample varied from 0
to 7.1, 6.82 to 2.86, 1.57 to 1.54, and 1.83 to 0.23 in C1, C2, C3,
and C4, respectively. During this same period of time, the
mean Ds/Dn values increased from 0 to 1.85 in C5, whose viral
population was extremely homogeneous at days 7 and 48. In-
terestingly, the increase in the number of nonsynonymous sub-
stitutions was highest in C4, who was born to a mother sero-
negative for V3 epitopes and in whom autochthonous
antibodies to V3 epitopes could be documented at the esti-
mated age of 58 days (14). Therefore, although the changes in
the V3 region during the first 6 months of life might reflect
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FIG. 5. Molecular and genetic parameters in three slow-progressor (C1, C2, and C3) and two rapid-progressor (C4 and C5) HIV-1 infected infants. The patient
code is shown within each plot. (A) Copy number of HIV-1 RNA per milliliter of plasma (n), CD41-cell number (F), and intrasample viral diversity (). The genetic
diversity of the virus population was measured by the Simpson index (D), as detailed in Materials and Methods; the plot shows 1/D values for each sample at each time
point. (B) Mean values (6 standard errors) of synonymous (h) and nonsynonymous (n) substitutions. The numbers of synonymous and nonsynonymous substitutions
were calculated by using the method of Nei and Gojobori (40), incorporating the Jukes-Cantor correction for multiple substitutions, and expressed as percentages.
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immune selective pressures, both the genetic data and antibody
detection findings strongly argue against a role for the humoral
response in curtailing the virus after the initial peak in slow-
progressor infants. In contrast, during the second 6 months of
life, the increase in the number of nonsynonymous substitu-
tions was comparable to that for synonymous substitutions in
rapid-progressor infants C4 and C5 but exceeded that of syn-
onymous substitutions in all three slow progressors. The mean
Ds/Dn values varied from 0.23 to 0.51 in C4 and from 1.85 to
1.09 in C5 but varied from 7.1 to 0, from 2.86 to 1.20, and from
1.54 to 0.61 in C1, C2, and C3, respectively, thus suggesting a
stronger positive selection for changes in slow progressors than
in rapid progressors.
No relationship emerged between the evolution of the V3
domain and the viral phenotype. Indeed, analysis of the viral
phenotype at the time of first positive HIV-1 detection dis-
closed that three infants (C1, C4, and C5) had a rapid/high-
type virus according to the pattern of viral growth in primary
coculture (13, 43), but only one primary isolate (from C4)
displayed SI capacity in MT-2 cells. Further studies performed
at the last time point of genetic analysis disclosed that no shift
in the viral phenotype had occurred in slow- or rapid-progres-
sor infants (data not shown).
DISCUSSION
Infants with perinatally transmitted HIV-1 infection show
two different patterns of disease outcome within their first
months of life: some develop severe symptoms of disease and
rapidly progress to AIDS, while others show a variable period
of clinical latency. We studied the transmission and evolution
of HIV-1 in two rapid- and three slow-progressor infants by
analyzing maternal samples collected at delivery and sequen-
tial samples from infants collected over their first year of life.
All but one of the infants studied were negative for viral
markers at birth. This would suggest that they were most likely
infected during the intrapartum period or close to the time of
delivery. Only child C5 gave positive results by PCR and virus
culture at first examination on day 7 after birth; in this case,
transmission could have occurred either in utero or during the
intrapartum period. Interpair phylogenetic analysis showed
that sequences from each mother-infant pair were clearly dis-
tinct from one another and were clustered in a star-shaped
phylogeny, indicating a pattern of evolution from a common
ancestral sequence. Given the lack of direct epidemiological
linkage between the pairs, this sequence may represent either
a general ancestral subtype B virus or a particular local ances-
tral strain. Intrapair phylogenetic analysis supported the no-
tion that a single V3 genetic variant initiated the infection in
the infant, in agreement with observations made by others (1,
38, 54, 65). This variant constituted the predominant form
within the viral population in the first sample from the child
and, with the exception of one case (C5), was found to be
related to a minor maternal variant in the blood, thus suggest-
ing a selective process during transmission or the first round of
viral replication in the new host. Interestingly, the predomi-
nant variants at 1 month of age in both children C1 and C4
were identical at the amino acid level to minor variants within
the maternal virus population, thus suggesting that selection
occurred during transmission. None of the sequences in chil-
dren C2 and C3 at 3 months of age showed identity with the
maternal sequences. Although transmission early in utero
could not be excluded in these two cases, it appears unlikely in
light of the negative findings at birth; therefore, a selection
following transmission might explain these results. Reports
that viral variants show different tissue distributions, and that
genital secretions may harbor viral variants distinct from those
in blood (44, 66), suggest the alternative explanation that trans-
mitted variants originate from sites distinct from the peripheral
blood compartment. In any case, the comparison of the se-
quence data with the patterns of plasma HIV-1 RNA levels
(Fig. 5) suggests that viral replication in the first month of life
leads to the expansion of the transmitted variant, while a se-
lection within the host may occur only after this first phase.
The selective transmission of unglycosylated V3 variants has
been demonstrated by some studies (65) although not con-
firmed in others (1, 54). Moreover, previous studies (43, 62)
suggested that monocyte/macrophage-tropic variants are selec-
tively transmitted from mother to child and/or selectively rep-
licated upon transmission. In the present study, we found that
V3 glycosylation sites were highly conserved in both maternal
and infant sequences, except for the site upstream of the first
cysteine of the V3 domain (i.e., position 14 [Fig. 4]), which was
lacking in the majority of the sequences from mothers M3 and
M4 and in all the sequences from the first sample of their
infants. Furthermore, based on the presence of an uncharged
or acidic amino acid at positions 11, 13, 25, and 29 within the
V3 domain, most of the sequences in the mothers and infants
were potentially of the non-SI phenotype; in agreement with
this, all of the primary isolates from mothers and infants were
able to grow in monocyte-derived macrophage cultures. A few
maternal sequences predictive of the SI phenotype could be
detected in M2, M3, and M4, whose isolates also displayed SI
activity (43), but none of these sequences were found in their
infants, although the isolate from C4 retained SI activity.
Therefore, although no distinctive pattern could be seen be-
tween transmitted and nontransmitted variants or between
rapid- and slow-progressor infants, these findings might sup-
port the notion of a positive selection of unglycosylated mono-
cyte/macrophage-tropic variants both during transmission and
during the first cycles of viral replication in the newborn.
A major difference between rapid- and slow-progressor in-
fants is that the latter are able to curtail and modulate viral
replication after the first phase of replication soon after birth
(16), thus confirming the evidence that high and persistent
levels of virus production are directly related to disease pro-
gression (37, 46). All of the infants in this study showed a rapid
increase in plasma HIV-1 RNA content soon after birth, but
this initial rise was followed by a decline in viral burden only in
the three slow progressors. Both the immune response and
viral phenotype may contribute in determining the different
patterns of HIV-1 replication and production. Specific V3 se-
quences were not detected in rapid- and slow-progressor in-
fants, suggesting that genetic polymorphism of the V3 region is
not directly related to the early onset of AIDS in infants. The
majority of the sequences persisted over time as the non-SI
potential phenotype in both rapid- and slow-progressor in-
fants, and accordingly, no changes in viral phenotype were
documented. Only one (C4) of the two rapid progressors had
an SI-type virus, and viral isolates from this child retained SI
characteristics despite the absence of SI-type sequences within
the V3 region. Although the presence of few variants with
SI-type sequences cannot be excluded, this finding, in agree-
ment with previous observations (9, 36), might indicate that
epitopes other than V3 may contribute to the SI capability of
the virus.
As the V3 domain contains recognition sites for both hu-
moral and cellular immune responses, variations within this
region would be informative about the positive selective forces
exerted by the host’s immune system. We found that genetic
variability increased over time and did not correlate with dis-
ease progression or CD41-cell decline. However, an analysis of
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the number of synonymous and nonsynonymous substitutions
revealed differences between rapid and slow progressors. In-
deed, during the second 6 months of life, the increase in the
number of nonsynonymous substitutions was comparable to
that of synonymous substitutions in the rapid-progressor in-
fants. Conversely, during the same period of age, the increase
in the number of nonsynonymous substitutions was higher than
that of synonymous substitutions in all three slow-progressor
infants, thus suggesting that an increase in genetic diversity in
the slow, but not in the rapid, progressors correlated with
positive selection for change. These findings differ from the
observations of Strunnikova et al. (58) and agree with recent
studies with adults showing that a greater HIV-1 population
complexity and a positive selection for nonsynonymous substi-
tutions correlates with a slower CD41-cell decline and a pro-
longed asymptomatic status (12, 33, 64).
Recent data support the idea that V3 genetic evolution is
mainly driven by host immune constraints (33, 64). In this
regard, it is noteworthy that of the two infants (C3 and C4)
who lacked an N-linked glycosylation site at position 14 in their
sequences soon after birth, only the slow progressor (C3)
showed variants with a potential glycosylation site at this po-
sition in subsequent samples. As N-linked glycosylation sites
could be important in the formation of conformational
epitopes and might mask linear epitopes, thus contributing to
the immune escape of viral mutant forms (2, 28, 56), the
different pattern observed in the two infants might reflect dif-
ferent immune pressure. However, it is noteworthy that during
the first 6 months of life, the patterns of synonymous and
nonsynonymous substitutions varied from child to child regard-
less of the disease progression status; furthermore, mean Ds/Dn
values were decreased in all three slow-progressor infants at
the last time point, thus indicating that positive selection for
changes occurred primarily in the second semester of life. This
is of particular interest, because in the three slow-progressor
infants viral decline occurred earlier, during the third month of
life. Taking into consideration the proposal that positive selec-
tion for amino acid changes in V3 is driven mainly by host
immune system forces, these findings suggest that the immune
response to V3 contributes to regulating viral levels after the
first semester of life but is unlikely to play a determinant role
in curbing the virus after its rapid spread soon after birth.
Interestingly, child C4 developed early AIDS despite the onset
of antibody production against the V3 domain (14). It has been
proposed that cellular immunity rather than humoral immune
responses might play a role in restraining the virus after the
primary infection (4, 22, 31). The finding that HIV-1-specific
cytotoxic T lymphocytes are only rarely detected in infected
newborns (34, 35) and our observation that positive selection
for changes in V3 were detected mainly after the first semester
of life suggest that factors other than the immune response to
V3 play a crucial role in controlling virus replication soon after
birth.
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